Testing effectiveness (Phase 2)Looking for participantsNCT07308886
What this trial is testing
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 55